This page includes the latest FDA filings for Mirati Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | MRTX | DUNS 078870124 |
Device Company | Device | Date |
---|---|---|
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-08-09 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-06-29 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-03-28 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2024-02-23 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-06-23 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-01-11 |
Mirati Therapeutics, Inc, Asymchem Life Science (Tianjin) Co. Ltd. | Prescription Medication | 2023-01-06 |
MIRATI THERAPEUTICS, INC | 2022-12-13 19:58:45 | |
Mirati Therapeutics, Inc | KRAZATI | 2022-12-12 |
NCAGE Code | 8HE38 | MIRATI THERAPEUTICS, INC. |
CAGE Code | 8HE38 | MIRATI THERAPEUTICS, INC. MIRATI |
S.A.M. Registration | 8HE38 [78870124] | MIRATI THERAPEUTICS, INC. MIRATI |
SEC | 0001576263 | Mirati Therapeutics, Inc. of DELAWARE |